Incannex Healthcare Inc. IXHL
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -100.00% |
| SG&A Expenses | -3.24% | 64.33% | 30.90% | 65.33% | -29.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -81.33% | -13.44% | 60.42% | 16.10% | 22.99% |
| Operating Income | 81.33% | 13.44% | -60.89% | -17.67% | -23.22% |
| Income Before Tax | 92.12% | 2.14% | -10.64% | -18.21% | -391.42% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 92.12% | 2.14% | -10.64% | -18.21% | -389.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 92.12% | 2.14% | -10.64% | -18.21% | -389.13% |
| EBIT | 81.33% | 13.44% | -60.89% | -17.67% | -23.22% |
| EBITDA | 81.82% | 13.70% | -64.56% | -17.85% | -23.46% |
| EPS Basic | 98.22% | 94.81% | 94.42% | 93.28% | -0.29% |
| Normalized Basic EPS | 98.19% | 93.08% | 94.42% | 93.28% | 0.77% |
| EPS Diluted | 98.22% | 94.81% | 94.42% | 93.28% | -0.29% |
| Normalized Diluted EPS | 98.19% | 93.08% | 94.42% | 93.28% | 0.77% |
| Average Basic Shares Outstanding | 343.31% | 1,787.00% | 1,882.77% | 1,658.83% | 387.76% |
| Average Diluted Shares Outstanding | 343.31% | 1,787.00% | 1,882.77% | 1,658.83% | 387.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |